Issue Tek Sakura Tatcham Uk Cassett

Lab Reagents

Human IgG antibody Laboratories manufactures the issue tek sakura tatcham uk cassett reagents distributed by Genprice. The Issue Tek Sakura Tatcham Uk Cassett reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact sakura tissue tek. Other Issue products are available in stock. Specificity: Issue Category: Tek Group: Sakura Tatcham

Sakura Tatcham information

UK 14,304
B3465-10 10 mg
EUR 190

UK 14,304
B3465-100 100 mg
EUR 1027

UK 14,304
B3465-5 5 mg
EUR 139

UK 14,304
B3465-50 50 mg
EUR 595

UK 383367
E1KS2224 10mg
EUR 325

UK-157147
HY-100319 10mg
EUR 3361

UK-371804
HY-101214 100mg
EUR 1359

UK 356618
HY-107394 10mg
EUR 739

UK-240455
HY-19391 5mg
EUR 2809

UK-383367
HY-13102 10mg
EUR 147

UK-5099
HY-15475 10mM/1mL
EUR 156

UK-1
GL9453-1MG 1 mg
EUR 309

UK-1
GL9453-250UG 250 ug
EUR 149

UK-5099
A3899-10 10 mg
EUR 174
Description: UK-5099 is a potent inhibitor of the mitochondrial pyruvate carrier [1]. The mitochondrial pyruvate carrier (MPC) facilitates pyruvate transport across the mitochondrial inner membrane and plays a critical role in carbohydrate, lipid and amino acid metabolism.

UK-5099
A3899-50 50 mg
EUR 551
Description: UK-5099 is a potent inhibitor of the mitochondrial pyruvate carrier [1]. The mitochondrial pyruvate carrier (MPC) facilitates pyruvate transport across the mitochondrial inner membrane and plays a critical role in carbohydrate, lipid and amino acid metabolism.

UK 383367
A4354-10 10 mg
EUR 147
Description: UK 383367 is a novel procollagen C-protein (PCP) inhibitor being investigated for the treatment of post-surgical dermal scarring, which potently inhibits the activity of PCP with the value of 50% inhibition concentration IC50 of 44 nM.

UK 383367
A4354-25 25 mg
EUR 244
Description: UK 383367 is a novel procollagen C-protein (PCP) inhibitor being investigated for the treatment of post-surgical dermal scarring, which potently inhibits the activity of PCP with the value of 50% inhibition concentration IC50 of 44 nM.